Evidence map›Paper›PMID 38400099›Full record

ArticleVaccines2024

Adjuvanted Vaccine Induces Functional Antibodies against

Valery C Román-Cruz, Shannon M Miller, Roman A Schoener, Chase Lukasiewicz, Amelia K Schmidt, Blair L DeBuysscher, David Burkhart, Patrick R Secor, Jay T Evans

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Valery C Román-CruzDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Shannon M MillerInimmune Corporation, Missoula, MT 59802, USA.
Roman A SchoenerInimmune Corporation, Missoula, MT 59802, USA.
Chase LukasiewiczCenter for Translational Medicine, University of Montana, Missoula, MT 59812, USA.
Amelia K SchmidtDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Blair L DeBuysscherCenter for Translational Medicine, University of Montana, Missoula, MT 59812, USA.
David BurkhartCenter for Translational Medicine, University of Montana, Missoula, MT 59812, USA.
Patrick R SecorDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Jay T EvansDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.ORCID 0000-0001-6602-0272
University of Montana · US

Funding

Immunization against filamentous bacteriophages to prevent bacterial infectionR01AI138981 · NIAID · UNIVERSITY OF MONTANA · PI EVANS, JAY T. · 2018 to 2022
$5.4M
NIAID NIH HHS R01 AI138981NIH HHS R01AI138981-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantPf bacteriophagePseudomonas aeruginosaTLR4 agonistvaccine

Identifiers

PMID38400099
PMCPMC10892371
OpenAlexW4391211348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.